Hopes for reversing age-associated effects in MS patients

Credit: Dr David Furness - Wellcome Images images@wellcome.ac.uk.

Proof of principle study suggests the age-associated decline of the remyelination process is reversible

Neuro-tweets: #hashtagging the brain

We like to think the human brain is special, something different from other brains and information processing systems, but a Cambridge professor set out to test that assumption - by conducting a live experiment using Twitter.

Research award for the battle against glaucoma

A Cambridge University researcher investigating eye cell transplants in the battle against glaucoma has been awarded £200,000 by the Fight for Sight charity.

Campath: from innovation to impact

The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

Brain stem cell discovery

Insight could lead to new therapies to repair damage caused by MS.

Glaucoma: the silent thief of sight

New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.

A brain chemical changes locusts from harmless grasshoppers to swarming pests

Scientists have uncovered the underlying biological reason why locusts form migrating swarms. Their findings, reported in today’s edition of Science, could be used in the future to prevent the plagues which devastate crops (notably in developing countries), affecting the livelihood of one in ten people across the globe.